Biomedicine

NewCardio Adds Gari Clifford, Ph.D., to Technology Development Team

Published in Cardiovascular Business Week, March 4th, 2008

NewCardio, Inc., (OTCBB: NWCI) a development-stage cardiac diagnostic and services company, announced that it has entered into a long-term consulting agreement with Gari Clifford, Ph.D. Under terms of the agreement, Dr. Clifford will assist with the development of the Company's platform technology in collaboration with NewCardio's technology team.

Dr. Clifford is currently a Principal Research Scientist at the Harvard-MIT Division of Health Sciences, where he is the engineering manager of a National Institute of Health (NIH)-funded research program "Integrating Data, Models, and Reasoning in Critical Care," and a major contributor to the well-known Physionet Research...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Business Week

Source: Cardiovascular Business Week (2008-03-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry